{
    "clinical_study": {
        "@rank": "9835", 
        "arm_group": {
            "arm_group_label": "Expert Reviewer's Assessment/DeVilbiss AutoAdjust CPAP device", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this protocol is to improve the current FDA-approved continuous positive\n      pressure auto-titration algorithm, including treatment precision, residual disease detection\n      characteristics and phenotyping with the DeVilbiss brand AutoAdjust CPAP device."
        }, 
        "brief_title": "Revised Algorithm for Next Generation DeVilbiss Healthcare AutoAdjust Continuous Positive Airway Pressure (CPAP)", 
        "condition": "Obstructive Sleep Apnea", 
        "condition_browse": {
            "mesh_term": [
                "Sleep Apnea Syndromes", 
                "Sleep Apnea, Obstructive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Apnea hypopnea index \u2265 10 / hour of sleep on the diagnostic polysomnogram (or\n             diagnostic component of a split night polysomnogram)\n\n          -  Compliant use (averaging 4 or more hours nightly)\n\n          -  Age 21-64 years\n\n        Exclusion Criteria:\n\n          -  Congestive heart failure\n\n          -  Chronic obstructive lung disease requiring supplemental oxygen\n\n          -  Chronic renal failure stroke\n\n          -  Neurodegenerative disorders\n\n          -  Uncontrolled psychiatric illnesses."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "64 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01797705", 
            "org_study_id": "DHC-002"
        }, 
        "intervention": {
            "arm_group_label": "Expert Reviewer's Assessment/DeVilbiss AutoAdjust CPAP device", 
            "intervention_name": "DeVilbiss AutoAdjust CPAP", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 3, 2014", 
        "location": {
            "contact": {
                "email": "rthomas1@bidmc.harvard.edu", 
                "last_name": "Robert J Thomas, MD", 
                "phone": "617-667-5864"
            }, 
            "facility": {
                "address": {
                    "city": "Newton", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02459"
                }, 
                "name": "NeuroCare, Inc."
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Revised Algorithm for Next Generation DeVilbiss AutoAdjust CPAP", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The purpose of this protocol is to improve the current FDA-approved continuous positive pressure auto-titration algorithm, including treatment precision, residual disease detection characteristics and phenotyping. The study will categorize sleep apnea subjects as \"obstructive\" vs. \"chemoreflex mediated\" in a dichotomous manner, compared to phenotyping using conventional polysomnography and AASM (american association of sleep medicine) 2012 scoring/phenotyping. Efficacy will determine concordance with human manual titration decisions, with success defined as 80% concordance of decisions in stable and unstable NREM (non-rapid eye movement) sleep, and supine REM (rapid eye movement) sleep.", 
            "measure": "The purpose of this protocol is to improve the current FDA-approved continuous positive pressure auto-titration algorithm, including treatment precision, residual disease detection characteristics and phenotyping.", 
            "safety_issue": "No", 
            "time_frame": "Up to 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01797705"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "DeVilbiss Healthcare LLC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "DeVilbiss Healthcare LLC", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}